NCT06871293Recruiting
Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19
Impact of Functional and Cognitive Rehabilitation, in Adults With Chronic Noncommunicable Diseases and Long Covid-19 , on Their Functional and Cognitive Capacity, Quality of Life, and the Evolution of Their Baseline Condition, in Bogotá D.C.
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
This study aims to evaluate the impact of a functional and cognitive rehabilitation strategy compared to evidence-based informational messages, on functional capacity, cognitive abilities, quality of life, and disease progression in adults with chronic non-communicable diseases (NCDs) and Long Covid-19. Researchers will compare a structured rehabilitation program to informational support through evidence-based messages to determine if rehabilitation leads to better functional and cognitive outcomes in patients with Long Covid-19. Participants will be randomly assigned to one of two groups: 1. Functional and cognitive rehabilitation: Attending weekly in-person sessions for 8 weeks, including supervised physical and cognitive exercises. 2. Informational support: Receiving weekly evidence-based educational messages for 8 weeks. Participants will undergo assessments at baseline, post-intervention, and six months later, including a six-minute walk test, handgrip strength measurement, and questionnaires on disability, anxiety, depression, fatigue, dyspnea, cognitive function, and quality of life.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 374 (estimated)
- First submitted
- 5 Mar 2025
- Start date
- 30 Oct 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Fundación Cardioinfantil Instituto de Cardiología
- Diseases
- High blood pressure, Long COVID and ME/CFS
- NCT number
- NCT06871293
What you commit to
- Study type: Interventional
- Planned participants: 374
- From 30 Oct 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Severely advanced baseline comorbidities prior to SARS-CoV-2 infection.
- Two hospitalizations in the year prior to admission to the institutional registries of the FCI-IC and the HOMIL for the patient's underlying disease.
Lab values
- Presence of chronic respiratory disease (partial or permanent supplemental oxygen use), cardiac failure (LVEF\<40%) or advanced renal disease (GFR\<30%).
- heart failure (LVEF\<40%) or advanced renal disease (GFR\<30).
Age
- Age \>80 years.
Other
- Dependence on a caregiver.
- Orthopedic or cardiopulmonary problems that contraindicate the performance of aerobic exercise.
- Neuropsychiatric or cognitive limitations that limit understanding or following commands and performing attention exercises.
Who the study is looking for
- Covid-19 confirmed.
- History of arterial hypertension or diabetes mellitus before entering the institutional registries of the FCI-IC or HOMIL, institutional registries of the FCI-IC or HOMIL or before having the diagnosis of SARSCoV-2 infection.
- Persistence of two or more concurrent symptoms, related to Covid-19 prologue, for at least 4 weeks (persistent, intermittent, or intermittent).
- At least one of these symptoms must have an impact on activities of daily living. They can be physical (fatigue, dyspnea, myalgias, arthralgias) or neuropsychiatric (cognitive, sleep and emotional alterations).
- Symptoms unexplained by underlying disease or other condition concomitant with SARS-CoV-2 infection. SARS-CoV-2 infection (determined by prior medical history review and participant interview).
- participant interview).
- \- Ability to read and attend functional and cognitive rehabilitation sessions or to receive the with evidence-based informational messages.
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fundación Cardioinfantil-Instituto de cardiología Coordinator of this site? Confirm its status | Bogotá | Colombia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.